KVD-998052

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameKVD-998052
Drug Alias NameKV-998052
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasma kallikrein inhibitors
TargetsPlasma kallikrein
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVantia Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVantia Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A